Publication Ethics

Updated: 13/9/2026

Publication Ethics and Malpractice Statement

The Journal of Basic and Applied Research in Biomedicine is firmly committed to upholding the highest standards of publication ethics and actively adheres to the guidelines set by the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE). This statement outlines the ethical expectations for authors, editors, and reviewers, and addresses concerns related to authorship, plagiarism, data integrity, peer review, conflicts of interest, and other misconduct.

1. Authorship and Responsibility

Authorship should be limited to those who have made substantial contributions to the research. This includes: designing the study; acquiring or analyzing data; drafting and revising the manuscript; approving the final version for publication; and accepting accountability for all aspects of the work. (The full four-criteria ICMJE test authors are held to is set out on the Author Guidelines page.)

Submission implies that all listed authors have read and approved the final manuscript and consent to its submission. All authors must take responsibility for the accuracy, integrity, and ethical conduct of the study.

2. Plagiarism

Plagiarism, whether intentional or unintentional, is treated as a serious breach of publication ethics. This includes copying text, data, or figures without proper citation; rephrasing another author’s ideas without acknowledgment; and submitting someone else’s work as one’s own.

All submitted manuscripts are screened using plagiarism-detection software. The specific similarity thresholds and the correction/rejection process are set out in the Journal Policies “Plagiarism Policy” — a manuscript is not automatically rejected for any detected overlap; the similarity report is reviewed by an editor, since properly cited material and standard methodological phrasing can register as overlap without constituting plagiarism. Confirmed plagiarism discovered in an already-published article will result in correction or retraction (see Journal Policies, “Retraction and Correction Policy”). Authors’ institutions may be notified in serious cases. Responsibility for originality lies solely with the author(s).

3. Duplicate and Redundant Publication

Manuscripts must be submitted exclusively to jbarbiomed and should not have been previously published or be under consideration elsewhere. Substantial overlap with previously published work, even in a different language, without proper disclosure is considered duplicate publication and will lead to rejection. Salami slicing — dividing one study into several publications — is discouraged unless scientifically justified.

4. Data Fabrication and Falsification

Manipulating or fabricating data, images, or results is a serious breach of ethics and will not be tolerated. Any such misconduct will result in manuscript rejection or retraction of published articles and may lead to notification of institutional authorities.

5. Citation Manipulation

Citations must be relevant, necessary, and based on merit. Unjustified self-citation or coercive citation aimed at inflating citation metrics (e.g., h-index) is considered unethical and will be addressed by editorial action.

6. Ethical Approval

Research involving human or animal subjects must have prior approval from a recognized institutional ethics committee, and authors must state the approval number and date within the manuscript. The specific requirements — Declaration of Helsinki compliance, informed consent wording, IACUC approval for animal studies, and clinical trial registration — are set out in full in the Journal Policies “Human and Animal Studies” section.

7. Intellectual Property Rights

Authors are expected to respect intellectual property laws, including copyrights, trademarks, and licensing. All data and materials used in the research must be legally obtained and properly cited. (Licensing terms for the published article itself are set out in the Journal Policies “Copyright Policy.”)

8. Conflicts of Interest and Funding Disclosure

All authors must declare any financial or non-financial conflicts of interest that could influence the research or its interpretation. Funding sources must be disclosed in the manuscript, including institutional, private, or corporate support. (The full conflicts-of-interest policy, including reviewer/editor recusal rules, is set out in the Journal Policies “Conflicts of Interest” section.)

9. Responsibilities of Reviewers

  • Reviewers serve voluntarily and must maintain confidentiality and objectivity.
  • They should decline review requests if they lack expertise, are time-constrained, or have a potential conflict of interest.
  • Reviews must be constructive, evidence-based, and free from personal bias.
  • Reviewers are expected to identify uncited relevant work and report any ethical concerns to the editor.

10. Peer Review Process

jbarbiomed employs a double-blind peer review process to ensure manuscripts meet scientific and ethical standards before publication. The full workflow, reviewer count, decision timeline, and rejection criteria are set out in the Journal Policies “Peer-review Policy.”

11. Disclaimer

The publisher, editors, and co-publishers of jbarbiomed accept no responsibility for: injuries or damages arising from the use of published materials; any libelous statements or infringements of rights; or product claims or instructional errors within published content. All content is published in good faith, and the responsibility for scientific accuracy and legal compliance lies solely with the authors.